Bicocca Open Archive

Logo unimib boa
SINICO, RENATO ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.441
AS - Asia 13.079
EU - Europa 10.339
SA - Sud America 1.911
Continente sconosciuto - Info sul continente non disponibili 1.349
AF - Africa 285
OC - Oceania 27
Totale 53.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.405
SG - Singapore 4.980
IT - Italia 3.073
CN - Cina 2.415
HK - Hong Kong 2.207
CA - Canada 1.817
RU - Federazione Russa 1.739
BR - Brasile 1.441
VN - Vietnam 1.289
IE - Irlanda 1.284
SE - Svezia 901
DE - Germania 860
GB - Regno Unito 550
BD - Bangladesh 533
FR - Francia 517
UA - Ucraina 374
TR - Turchia 339
FI - Finlandia 314
IN - India 288
AT - Austria 237
AR - Argentina 162
JP - Giappone 134
IQ - Iraq 132
KR - Corea 125
MX - Messico 100
PK - Pakistan 97
ES - Italia 87
NL - Olanda 83
ZA - Sudafrica 81
ID - Indonesia 80
SA - Arabia Saudita 76
EC - Ecuador 67
CO - Colombia 65
DK - Danimarca 62
VE - Venezuela 59
PH - Filippine 55
UZ - Uzbekistan 47
PL - Polonia 43
CL - Cile 41
MY - Malesia 41
EG - Egitto 40
MA - Marocco 32
EU - Europa 30
PY - Paraguay 29
RO - Romania 29
BE - Belgio 25
KE - Kenya 25
AE - Emirati Arabi Uniti 24
IL - Israele 24
GR - Grecia 23
AU - Australia 22
JM - Giamaica 21
TH - Thailandia 21
UY - Uruguay 21
HN - Honduras 19
JO - Giordania 19
NP - Nepal 19
PE - Perù 19
DZ - Algeria 18
CH - Svizzera 17
OM - Oman 17
LT - Lituania 16
TN - Tunisia 16
ET - Etiopia 15
PT - Portogallo 15
AL - Albania 14
IR - Iran 14
KZ - Kazakistan 14
CR - Costa Rica 13
CZ - Repubblica Ceca 13
LB - Libano 13
AZ - Azerbaigian 11
BG - Bulgaria 11
BH - Bahrain 10
NO - Norvegia 10
PS - Palestinian Territory 10
NG - Nigeria 9
PA - Panama 9
SV - El Salvador 9
HU - Ungheria 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
SY - Repubblica araba siriana 7
AO - Angola 6
KG - Kirghizistan 6
SN - Senegal 6
CY - Cipro 5
DO - Repubblica Dominicana 5
GA - Gabon 5
MD - Moldavia 5
PR - Porto Rico 5
SC - Seychelles 5
TW - Taiwan 5
CI - Costa d'Avorio 4
HR - Croazia 4
KH - Cambogia 4
LY - Libia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
Totale 52.031
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.898
Singapore 2.889
Hong Kong 2.174
Woodbridge 2.066
Ashburn 1.644
Toronto 1.394
Chandler 1.358
Houston 1.254
Dublin 1.221
Fairfield 1.046
San Jose 952
Milan 877
Dearborn 832
Wilmington 801
Jacksonville 787
New York 678
Princeton 546
Frankfurt am Main 532
Chicago 447
The Dalles 433
Seattle 427
Santa Clara 409
Ho Chi Minh City 403
Dallas 392
Los Angeles 367
Cambridge 361
Beijing 321
Hanoi 273
Nanjing 258
Moscow 250
Lawrence 244
Lauterbourg 241
Rome 220
Altamura 212
Vienna 208
Lachine 195
Boardman 191
Buffalo 144
Shanghai 143
São Paulo 132
Council Bluffs 130
Lissone 124
San Diego 112
Hefei 109
Ottawa 105
Seoul 95
Guangzhou 94
Andover 83
Helsinki 76
Nanchang 76
Shenyang 74
Tokyo 71
Columbus 69
London 68
Munich 64
Hebei 60
Norwalk 59
Orem 59
Turin 56
Baghdad 55
Washington 55
Falls Church 54
Changsha 52
Nuremberg 52
Tianjin 51
Jakarta 48
Salt Lake City 46
Da Nang 45
Rio de Janeiro 45
Phoenix 44
Atlanta 43
Brooklyn 43
Figino 42
Jiaxing 42
Naples 42
Dhaka 41
Montreal 41
Tashkent 41
Jinan 40
Philadelphia 39
Denver 38
San Francisco 37
Haiphong 36
Mountain View 36
Florence 35
Warsaw 34
Dong Ket 33
Belo Horizonte 32
Zhengzhou 32
Jeddah 31
Boston 30
Chennai 28
Lahore 28
Johannesburg 27
New Delhi 27
Tampa 27
Hangzhou 25
Redmond 25
Curitiba 24
Istanbul 24
Totale 34.374
Salva come PNG Salva come JPEG
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 717
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 598
Modifications in peripheral-blood lymphocyte subpopulations induced by plasmapheresis and immunosuppressive drugs 489
Microscopic Polyangiitis 435
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 408
MALDI imaging in Fabry nephropathy: a multicenter study 402
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 398
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 390
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 384
Kidney Involvement 376
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 360
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 350
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 332
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 331
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 315
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 306
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 303
Renal involvement in Churg-Strauss syndrome 302
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 298
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 296
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 293
Novel Therapies in Takayasu Arteritis 287
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 285
Neutrophil Extracellular Traps in the Autoimmunity Context 283
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 281
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 276
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 275
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 269
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 267
Eosinophilic granulomatosis with polyangiitis (churg-straus syndrome) 264
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 261
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 260
117. Prediction of Long-Term Evolutionary Profiles in Eosinophilic Granulomatosis with Polyangiitis (Churg– Strauss) Based on Baseline and Follow-Up Characteristics 259
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 258
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 257
Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies 255
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 255
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 253
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 251
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study 250
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion 250
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 249
Goodpasture syndrome and anti-glomerular basement membrane disease 248
Systemic Vasculitis and Pregnancy: a Multicenter Study On Maternal and Neonatal Outcome of 43 Prospectively Followed Pregnancies 243
CLINICAL FEATURES AND RENAL PROGNOSIS IN LUPUS NEPHRITIS PATIENTS UNDERGOING A REPEATED BIOPSY: RESULTS OF 103 RE-BIOPSIES IN 438 PATIENTS 243
AB0511 International Consensus on ANCA Testing and Interpretation Beyond Systemic Vasculitis 243
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 243
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 240
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 239
Immunology of membranous nephropathy: From animal models to humans 238
Anticoagulant-related nephropathy: a pathological note 235
Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy 233
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 233
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 232
Evidence for charge-based mimicry in anti dsDNA antibody generation 231
Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients 231
Milder clinical presentation of lupus nephritis and improved renal survival during the last 50 years: a multicentric study 231
RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS 229
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 229
Sneddon's syndrome: clinical and immunohistochemical findings 225
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 224
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature 224
Renal involvement in eosinophilic granulomatosis with polyangiitis 223
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 222
Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity? 222
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 221
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome 220
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 216
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 216
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 216
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 215
T-lymphocyte subsets in primary and secondary glomerulonephritis 215
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 215
Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis 214
ANCA-associated vasculitis in childhood: Recent advances 213
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis [Position paper] 213
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 213
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 211
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 210
Multiple hepatic abscesses complicating continuous ambulatory peritoneal dialysis 210
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases 210
Plasma-exchange and glomerulonephritis 209
Role and clinical significance of rheumatoid factors in glomerulonephritis 207
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 206
ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE) 203
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies 202
Lymphocyte populations in the peripheral blood from patients with IgA nephropathy 201
255. Renal involvement in EGPA: a multicentre retrospective study of 63 cases 201
A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: A retrospective study of 47 patients 200
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 200
Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis 200
The Role of Rituximab in Primary Focal Segmental Glomerulosclerosis of the Adult 200
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide 199
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 198
alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications 198
P0346THE EFFECTS OF RITUXIMAB MAINTENANCE THERAPY ON LUPUS NEPHRITIS 197
B lymphocyte subpopulations and T-cell subsets in primary chronic glomerulonephritis 196
Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: A comparison of different assays 196
Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease) 195
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 195
Totale 26.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.756 0 295 405 193 210 197 143 152 134 167 311 549
2022/20234.801 660 1.264 341 370 411 810 48 225 403 40 145 84
2023/20243.668 125 126 133 145 514 939 752 94 328 59 58 395
2024/20257.801 481 894 322 373 774 247 622 356 806 1.071 527 1.328
2025/202617.699 1.411 668 1.314 1.278 2.022 1.014 2.108 866 1.521 1.199 2.285 2.013
2026/2027976 679 297 0 0 0 0 0 0 0 0 0 0
Totale 53.431